Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FEGPL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,421
Award facts
- Contract value 100% obligated
- $20,420.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,420.87 to AmerisourceBergen Drug Corp for the supply of Cimzia 2x200 mg/ml syringe kits. The contract, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other military healthcare systems. The IDC vehicle through which this delivery order was issued functions as a comprehensive global pharmaceutical support contract, enabling the company to supply a diverse range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. Cimzia, a TNF inhibitor used to treat inflammatory conditions including rheumatoid arthritis and Crohn's disease, represents a specialized pharmaceutical product consistent with AmerisourceBergen's portfolio of therapeutic medications supplied through the federal procurement system.
Quick answers
Who was awarded contract SPE2DB25FEGPL?
SPE2DB25FEGPL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FEGPL worth?
The government has obligated $20,421 on SPE2DB25FEGPL.
Is contract SPE2DB25FEGPL an order under another contract?
Yes. SPE2DB25FEGPL is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEGPL competed?
The extent of competition for SPE2DB25FEGPL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award